Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

被引:0
|
作者
Zhang, Xinyue [1 ,2 ]
Yang, Jie [1 ,2 ]
Xiang, Yang [1 ]
Wu, Ming [1 ]
Cao, Dongyan [1 ]
Wang, Jinhui [1 ]
Yang, Jiaxin [1 ,2 ]
机构
[1] Peking Union Med Coll Hosp, Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Ovarian Neoplasms; Ovarian Diseases; PROGNOSTIC-FACTORS; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1136/ijgc-2024-005489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2-147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Liu, Ying L.
    Manning-Geist, Beryl L.
    Knezevic, Andrea
    Deng, Luxue
    Bromberg, Maria
    Funt, Samuel A.
    Meisel, Jane L.
    Zivanovic, Oliver
    Roche, Kara Long
    Sonoda, Yukio
    Gardner, Ginger J.
    Grisham, Rachel N.
    O'Cearbhaill, Roisin E.
    Tew, William P.
    Abu-Rustum, Nadeem R.
    Chi, Dennis S.
    Aghajanian, Carol
    Feldman, Darren R.
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 93 - 101
  • [2] Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Manning-Geist, Beryl
    Deng, Luxue
    Knezevic, Andrea
    Bromberg, Maria
    Funt, Samuel
    Zivanovic, Oliver
    Roche, Kara Long
    Sonoda, Yukio
    Gardner, Ginger
    Grisham, Rachel
    O'Cearbhaill, Roisin
    Abu-Rustum, Nadeem
    Chi, Dennis
    Aghajanian, Carol
    Feldman, Darren
    Liu, Ying
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S66 - S67
  • [3] Postrecurrence survival for pediatric extracranial malignant germ cell tumors: A report from the Malignant Germ Cell Tumors International Collaborative (MaGIC) Group.
    Shaikh, Furqan
    Dang, Ha
    Krailo, Mark D.
    Hale, Juliet
    Nicholson, James
    Rodriguez-Galindo, Carlos
    Olson, Thomas Arthur
    Murray, Matthew
    Amatruda, James
    Thornton, Claire Look
    Arul, Suren
    Billmire, Deborah
    Frazier, A. Lindsay
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Malignant ovarian germ cell tumors
    Chow, SN
    Yang, JH
    Lin, YH
    Chen, YP
    Lai, JI
    Chen, RJ
    Chen, CD
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 53 (02) : 151 - 158
  • [5] Management of Malignant Ovarian Germ Cell Tumors
    Parkinson, Christine A.
    Hatcher, Helen M.
    Ajithkumar, Thankamma V.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2011, 66 (08) : 507 - 514
  • [6] Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2015, 137 (03) : 418 - 422
  • [7] Malignant ovarian germ cell tumors - clinical characteristics and analysis of outcomes
    Miedzinska-Maciejewska, Magdalena
    Bobkiewicz, Piotr
    Gawrychowski, Krzysztof
    GINEKOLOGIA POLSKA, 2011, 82 (05) : 338 - 343
  • [8] Ovarian Malignant Germ Cell Tumors: Cellular Classification and Clinical and Imaging Features
    Shaaban, Akram M.
    Rezvani, Maryam
    Elsayes, Khaled M.
    Baskin, Henry, Jr.
    Mourad, Amr
    Foster, Bryan R.
    Jarboe, Elke A.
    Menias, Christine O.
    RADIOGRAPHICS, 2014, 34 (03) : 777 - 801
  • [9] Application of the adult International Germ Cell Classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the children's oncology group
    Frazier, A. Lindsay
    Rumcheva, Paviina
    Olson, Thomas
    Giller, Roger
    Cushing, Barbara
    Cullen, John
    Marina, Neyssa
    London, Wendy B.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 746 - 751
  • [10] UPDATE ON MALIGNANT OVARIAN GERM-CELL TUMORS
    GERSHENSON, DM
    CANCER, 1993, 71 (04) : 1581 - 1590